Physician

Deborah A Sambucci, D.O.

According to 2025 Medicare claims, Deborah Sambucci, D.O. (NPI: 1518167311) practices cardiology in the Camden, NJ market, with the plurality of this provider's patient population coming from Camden, NJ. This provider's primary affiliated billing organization is CARDIOVASCULAR ASSOCIATES OF THE DELAWARE VALLEY,P A (NPI: 1366495632; TIN: 223321233) and primary practice location at 08035-1715.

Sambucci's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,927 traditional Medicare patients, billed 8,366 HCPCS/CPT codes, and received $1,114,233 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 5,457 prescription claims across 942 beneficiaries totaling $986,970 in drug costs, led by Eliquis (Apixaban). 2017 DME data shows 16 claims. Open Payments data shows 93 records totaling $1,488. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $184,478 to $986,970. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,048	10,513	$1,045,061
2016	1,934	9,147	$788,313
2017	1,902	6,357	$709,999
2018	1,503	4,956	$575,024
2019	1,546	4,975	$537,694
2020	1,473	4,807	$617,387
2021	1,713	5,775	$656,812
2022	1,920	6,791	$856,329
2023	1,994	7,975	$1,156,713
2024	1,927	8,366	$1,114,233

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	426	2,086	$184,478
2016	447	2,494	$239,647
2017	533	2,980	$267,007
2018	555	3,194	$289,017
2019	563	3,183	$337,950
2020	627	3,621	$454,844
2021	695	3,906	$577,659
2022	752	4,202	$676,334
2023	780	4,731	$874,736
2024	942	5,457	$986,970

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	16	$357
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	462	465	$164
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	833	1,134	$72
93017	Exercise or drug-induced heart stress test with electrocardiogram (ecg)	312	312	$33
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	386	453	$14
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	1,066	1,417	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	297	21,975	$417,217
Xarelto	Rivaroxaban	108	7,890	$140,998
Repatha Sureclick	Evolocumab	119	6,670	$127,887
Entresto	Sacubitril/Valsartan	71	4,568	$94,154
Farxiga	Dapagliflozin Propanediol	32	2,750	$49,237

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	93	$1,488	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Deborah A. Sambucci, D.O.?

Tedicare shows public-source Medicare data for Deborah A. Sambucci, D.O. (NPI 1518167311), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Deborah A. Sambucci, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Deborah A. Sambucci, D.O.?

Deborah A. Sambucci, D.O. is linked to CARDIOVASCULAR ASSOCIATES OF THE DELAWARE VALLEY,P A (billing NPI 1366495632) in the available physician profile data.

Does Deborah A. Sambucci, D.O. have Open Payments data?

Deborah A. Sambucci, D.O. has 93 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.